Date | Shareholder name | Reason of Disclosure | Buy/Sell and Involved Shares |
Average Price per share | Current Holdings | % of Issued Shares |
12/04/2024 | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | ||
12/04/2024 | LuYe Pharmaceutical Investment Co., Ltd. | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | Shorea LBG | 1701(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | 1701(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | ||
12/04/2024 | Luye Pharma Holdings Ltd. | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | Luye Life Sciences Group Ltd | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | Ginkgo (PTC) Limited | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | Luye Pharma Hong Kong Limited | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | LuYe Pharmaceutical International Co., Ltd. | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | Luye Pharma Group Ltd. | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | Nelumbo Investments Limited | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | Liu Dianbo | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
12/04/2024 | AsiaPharm Investments Ltd. | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
1 |
Remark: | (L) - Long Position, (S) - Short Position, (P) Lending; |
Real time quote last updated: 28/06/2024 18:00 | |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |